Aug. 21, 2024
Controlled Clinical Trial Results for Lenire Tinnitus Treatment Device Published in Nature Communications
CHICAGO, ILLINOIS — Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial, which evaluated Lenire, the first and only FDA-approved bimodal tinnitus treatment device. The results, detailed in the paper titled “Combining Sound with Tongue Stimulation for the Treatment of Tinnitus: A Multi-Site Single-Arm Controlled Pivotal Trial,”